Management of Hypertensive Patients with Ventricular Ectopy and Supraventricular Tachycardia

Primary Management Strategy

The European Society of Cardiology recommends starting or optimizing RAAS blockade (ACE inhibitor or ARB) as the foundation of hypertension management, particularly in patients with likely left ventricular hypertrophy (LVH) suggested by the arrhythmia burden 1, 2, 3
Target systolic BP of 120-129 mmHg if well tolerated, as optimal BP control can reduce arrhythmia frequency, according to the European Heart Journal 3, 4
Aggressive BP control has been shown to reduce episodes of paroxysmal SVT, as reported in the European Heart Journal 4
The American College of Cardiology recommends initiating a beta-blocker (metoprolol succinate 50 mg daily or carvedilol 12.5 mg twice daily) as first-line therapy for symptomatic ventricular ectopy in hypertensive patients 1, 2, 5
Beta-blockers are preferred because they simultaneously address hypertension, reduce heart rate, and suppress ventricular ectopy, according to the European Heart Journal 1, 2

For brief SVT episodes, beta-blockers will help prevent SVT recurrence while controlling heart rate, as recommended by the American College of Cardiology 1, 5
If SVT episodes become more sustained or symptomatic despite beta-blocker therapy, consider referral for catheter ablation rather than escalating drug therapy, according to the American College of Cardiology and the European Heart Journal 2, 5

Obtain echocardiogram to assess for LVH, left ventricular systolic function, and structural heart disease, as recommended by the European Heart Journal 1, 2, 4
Check electrolytes (potassium, magnesium, calcium), renal function, thyroid function, and glucose, according to the European Heart Journal 2
Assess for precipitating factors: caffeine intake, alcohol use, sleep apnea, hyperthyroidism, anemia, as recommended by the European Heart Journal 1, 4

Eliminate caffeine and reduce alcohol intake, as these are common triggers for both PVCs and SVT, according to the European Heart Journal 4
Screen for and treat obstructive sleep apnea, which is common in hypertensive patients and can cause both bradyarrhythmias and tachyarrhythmias, as recommended by the European Heart Journal 1, 4
Implement DASH or Mediterranean diet, weight loss if BMI >25 kg/m², and regular aerobic exercise, according to the European Heart Journal 3

Refer for electrophysiology evaluation if SVT episodes become sustained (>30 seconds) or highly symptomatic despite medical therapy, as recommended by the American College of Cardiology and the European Heart Journal 2, 5
For re-entrant SVT and atrial flutter, catheter ablation has high success rates (>90%) and low complication rates, according to the European Heart Journal 2
For PVCs, consider ablation if burden remains >10-15% despite medical therapy and symptoms persist, as recommended by the European Heart Journal 2